Clinical Courses of IKAROS and CTLA4 Deficiencies: A Systematic Literature Review and Retrospective Longitudinal Study.

IKAROS 和 CTLA4 缺陷的临床病程:系统文献综述和回顾性纵向研究

阅读:6
作者:Hoshino Akihiro, Toyofuku Etsushi, Mitsuiki Noriko, Yamashita Motoi, Okamoto Keisuke, Yamamoto Michio, Kanda Kenji, Yamato Genki, Keino Dai, Yoshimoto-Suzuki Yuri, Kamizono Junji, Onoe Yasuhiro, Ichimura Takuya, Nagao Mika, Yoshimura Masaru, Tsugawa Koji, Igarashi Toru, Mitsui-Sekinaka Kanako, Sekinaka Yujin, Doi Takehiko, Yasumi Takahiro, Nakazawa Yozo, Takagi Masatoshi, Imai Kohsuke, Nonoyama Shigeaki, Morio Tomohiro, Latour Sylvain, Kanegane Hirokazu
IKAROS and CTLA4 deficiencies are inborn errors of immunity and show similar clinical phenotypes, including hypogammaglobulinemia and autoimmune diseases (ADs). However, the differences in clinical features and pathogenesis of these are not fully understood. Therefore, we performed systematic literature reviews for IKAROS and CTLA4 deficiencies. The reviews suggested that patients with IKAROS deficiency develop AD earlier than hypogammaglobulinemia. However, no study assessed the detailed changes in clinical manifestations over time; this was likely due to the cross-sectional nature of the studies. Therefore, we conducted a retrospective longitudinal study on IKAROS and CTLA4 deficiencies in our cohort to evaluate the clinical course over time. In patients with IKAROS deficiency, AD and hypogammaglobulinemia often develop in that order, and AD often resolves before the onset of hypogammaglobulinemia; these observations were not found in patients with CTLA4 deficiency. Understanding this difference in the clinical course helps in the clinical management of both. Furthermore, our results suggest B- and T-cell-mediated ADs in patients with IKAROS and CTLA4 deficiencies, respectively.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。